PRLD Intrinsic Valuation and Fundamental Analysis - Prelude Therapeutics Inc

	Prelude Therapeutics Inc NASDAQ:PRLD	US
D	Daphne International Holdings Ltd F:PSX	CN
W	WPP PLC F:0WP	UK
B	Bangchak Corporation PCL SET:BCP	TH
A	Avient Corp F:PY9	US
	Motivating Masses Inc OTC:MNMT	US
	SOL SpA F:QOL	IT
	Control Bionics Ltd ASX:CBL	AU
E	Estee Lauder Companies Inc XMUN:ELAA	US
R	Ratchaphruek Hospital PCL SET:RPH	TH
N	Namwiwat Medical Corp PCL SET:NAM	TH
	Castor Maritime Inc NASDAQ:CTRM	CY
	Cobre Ltd ASX:CBE	AU
	Guardant Health Inc NASDAQ:GH	US

Intrinsic Value

The intrinsic value for Prelude Therapeutics Inc (PRLD) under the Base Case is hidden USD. Compared with the current market price of 6.34 USD, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

Wall St target

$8.16

Do our valuations actually work? See backtest results .

PRLD Intrinsic Value

Unlock

PRLD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PRLD usually does or if today's premium is unusual.

See where today’s valuation sits in PRLD’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price $6.34

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Prelude Therapeutics Inc.

Explain Valuation